Xiaotian Chen - Concepedia

Author

Xiaotian Chen

AbbVie (United States)ORCID

Also Known As

Xiaotian Chen

Publications

276

Citations

H-Index

Concepts

All Affiliations

AbbVie (United States)The University of Texas MD Anderson Cancer Center University of Chicago Indiana University School of Medicine Indiana University – Purdue University Indianapolis

About

Xiaotian Chen is an author at AbbVie (United States) specializing in tumor biology, immunology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	48
2	Immunology	3	3	48
3	Engineering	2	2	23
4	Social Sciences	2	2	23
5	Cognitive Science	2	2	23

Xiaotian Chen

Publications

227

Citations

H-Index

Page 1

	Year	Citations
First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors Sarina A. Piha‐Paul, Jasgit C. Sachdev, Minal Barve, Clinical Cancer Research	2019	156
Results of the first-in-human study of ABBV-075 (mivebresib), a pan-inhibitor of bromodomain (BD) and extra terminal (BET) proteins, in patients (pts) with relapsed/refractory (R/R) solid tumors. Sarina A. Piha‐Paul, Jasgit C. Sachdev, Minal Barve, Journal of Clinical Oncology ImmunologyPathologyFirst-in-human StudyTumor BiologyCancer-associated Virus	2018	19
Results from the first-in-human study of mivebresib (ABBV-075), a pan-inhibitor of bromodomain and extra terminal proteins, in patients with relapsed/refractory acute myeloid leukemia. Olatoyosi Odenike, Johannes Wolff, Gautam Borthakur, Journal of Clinical Oncology Mixed-phenotype Acute LeukemiaImmunologyPathologyExtra Terminal ProteinsPharmacotherapy	2019	16
First-in-human study of ABBV-075 (mivebresib), a pan-inhibitor of bromodomain and extra terminal (BET) proteins, in patients (pts) with relapsed/refractory (RR) acute myeloid leukemia (AML): Preliminary data. Gautam Borthakur, Johannes Wolff, Ibrahim Aldoss, Journal of Clinical Oncology ImmunologyPathologyFirst-in-human StudyTumor BiologyMyeloid Neoplasia	2018	13
Adaptive Designs: Results of 2016 Survey on Perception and Use Alan Hartford, Mitchell A Thomann, Xiaotian Chen, Therapeutic Innovation & Regulatory Science Visual DesignCognitive ScienceEngineeringDesign EvaluationDesign	2020	12
Adaptive Designs: Results of 2016 Survey on Perception and Use Alan Hartford, Mitchell A Thomann, Xiaotian Chen, Therapeutic Innovation & Regulatory Science Visual DesignCognitive ScienceEngineeringDesign EvaluationDesign	2018	11

Page 1